Turkovac Explained

Drug Name:	Turkovac
Type:	vaccine
Target:	SARS-CoV-2
Vaccine Type:	inactivated
Legal Status:	Full list of Turkovac authorizations
Routes Of Administration:	Intramuscular
Synonyms:	ERUCOV-VAC

Turkovac^[1] (pronunciation: pronounced as /['tɜ:rkəvæk]/) is a COVID-19 vaccine developed by Turkish Ministry of Health and Erciyes University.__TOC__

Clinical trials

In November 2020, TURKOVAC started on phase I trials with 44 participants in Turkey.

In February 2021, TURKOVAC started on phase II trials with 250 participants in Turkey.

In June 2021, TURKOVAC started on phase III trials with 40,800 participants in Turkey. phase III trials continue.^[2]

Authorization

On 25 November 2021, the Turkish Minister of Health reported that Turkovac's application for emergency use authorization had been filed.^[3] On 22 December, Turkish President Recep Tayyip Erdogan announced the emergency use approval of Turkovac.^[4]

Notes and References

1. News: Cakmak BN . Turkey names home-grown COVID-19 jab Turkovac . Anadolu Agency . 22 June 2021.
2. Web site: ClinicalTrials.gov . 2024-01-16 . www.clinicaltrials.gov.
3. News: Turkey issues emergency-use authorization for its domestically produced vaccine.. 2021-12-28. The New York Times. 22 December 2021 .
4. News: 23 December 2021. Turkey authorises use of own Turkovac Covid-19 vaccine. France 24. 24 December 2021.